Patent details

Basic Information

Publication number:

EP2829265

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP141819300

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Novel formulations for treatment of migraine

French Title of Invention:

Compositions inédites destinées au traitement de la migraine

German Title of Invention:

Neuartige Formulierungen zur Behandlung von Migräne

SPC Number:

Dates

Filing date:

24/04/2009

Grant date:

24/08/2016

EP Publication Date:

24/08/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/01/2015

EP B1 Publication Date:

24/08/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/04/2017

Expiration date:

24/04/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/04/2009

 

 

Name:

Zogenix Inc.

Address:

5858 Horton Street Suite 455, Emeryville CA 94608, United States (US)

Inventor

1

Name:

Hawley Roger

Address:

United States (US)

2

Name:

Schuster Jeffrey A.

Address:

United States (US)

3

Name:

Turanin John

Address:

United States (US)

4

Name:

Farr Stephen J.

Address:

United States (US)

Priority

Priority Number:

48463

Priority Date:

28/04/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages